Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Packers' Jordan Love finds Tucker Kraft for 7-Yard TD to even score vs. Cardinals | NFL Highlights

    ‘We are witnessing greatness’ 👑 Big Papi, A-Rod, & Derek Jeter on Shohei Ohtani’s LEGENDARY NLCS

    Talladega Triumph Vaults Chase Briscoe into First Championship 4

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest VKontakte
    Sg Latest NewsSg Latest News
    • Home
    • Politics
    • Business
    • Technology
    • Entertainment
    • Health
    • Sports
    Sg Latest NewsSg Latest News
    Home»Health»Young children diagnosed with ADHD are often prescribed medication too quickly, study finds
    Health

    Young children diagnosed with ADHD are often prescribed medication too quickly, study finds

    AdminBy AdminNo Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    A new study released Friday found that young children diagnosed with attention-deficit/hyperactivity disorder, or ADHD, are often prescribed medication too quickly. 

    The study, led by Stanford Medicine and published in JAMA Network Open, examined the health records of nearly 10,000 preschool-aged children ages 3 to 5 between 2016 and 2023 who were diagnosed with ADHD.

    “ADHD is a disorder characterized by difficulty paying attention, or what we call hyperactivity, which is sort of like kids that have a hard time sitting still, they have a lot of energy,” explained Jamie Howard, a senior clinical psychologist with the Child Mind Institute, which specializes in treating anxiety and mood disorders in children. 

    Howard, who was not involved in the study, said that when treating ADHD in young children, clinical guidelines call for starting with “behavioral intervention.”

    “We always want to start with the lowest possible harm,” Howard said. “It does very little harm doing a behavioral intervention.”

    The Stanford study found that about 68% of those children who were diagnosed with ADHD were prescribed medications before age 7, most often stimulants such as Ritalin, which can help children focus their attention and regulate their emotions.

    The turn to medication often came quickly, according to the study. About 42% of the children who were diagnosed with ADHD were prescribed drugs within 30 days of diagnosis, the study found.  

    “We don’t have concerns about the toxicity of the medications for 4- and 5-year-olds, but we do know that there is a high likelihood of treatment failure, because many families decide the side effects outweigh the benefits,” Dr. Yair Bannett, assistant professor of pediatrics at Stanford Medicine and the lead author of the study, said in a statement. 

    Those side effects can include irritability, aggressiveness and emotional problems, according to Bannett.  

    “The high rate of medication prescriptions among preschool-age children with ADHD and the lack of delay between initial diagnosis and prescription require further investigation to assess the appropriateness of early medication treatment,” the researchers concluded.

    The study also found that the vast majority of the young children diagnosed with ADHD, about 76%, were boys.

    “I think that people have an association with ADHD and stimulant medication,” Howard said. “…But there is actually a lot more than that. And we want to give kids the opportunity to use these other strategies first, and then if they need medication, it can be incredibly helpful for a lot of kids.”

    More from CBS News

    Elaine Quijano

    Elaine Quijano is a weekend mornings anchor for CBS New York and a correspondent for CBS News and Stations, contributing to all CBS News, Stations and Streaming.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Admin
    • Website

    Related Posts

    Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO

    Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM USA – English APAC – English

    Antengene Presents Latest ATG-022 Clinical Data at ESMO 2025 Demonstrating Efficacy Across All CLDN18.2 Expression Levels and Exceptional Tolerability

    Planned 5-day strike at Kaiser Permanente facilities ends, further talks planned

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Judge reverses Trump administration’s cuts of billions of dollars to Harvard University

    Prabowo jets to meet Xi in China after deadly Indonesia protests

    This HP laptop with an astonishing 32GB of RAM is just $261

    Top Reviews
    9.1

    Review: Mi 10 Mobile with Qualcomm Snapdragon 870 Mobile Platform

    By Admin
    8.9

    Comparison of Mobile Phone Providers: 4G Connectivity & Speed

    By Admin
    8.9

    Which LED Lights for Nail Salon Safe? Comparison of Major Brands

    By Admin
    Sg Latest News
    Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
    • Get In Touch
    © 2025 SglatestNews. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.